WOCKHARDT BIO AG FDA Approval ANDA 075514

ANDA 075514

WOCKHARDT BIO AG

FDA Drug Application

Application #075514

Documents

Other Important Information from FDA2005-08-01

Application Sponsors

ANDA 075514WOCKHARDT BIO AG

Marketing Status

Prescription001

Application Products

001SOLUTION;ORALEQ 20MG BASE/5ML0FLUOXETINE HYDROCHLORIDEFLUOXETINE HYDROCHLORIDE

FDA Submissions

ORIG1AP2002-08-29
LABELING; LabelingSUPPL2AP2005-08-31
LABELING; LabelingSUPPL3AP2006-03-02
LABELING; LabelingSUPPL5AP2007-05-09
LABELING; LabelingSUPPL6AP2007-10-10
LABELING; LabelingSUPPL7AP2008-06-03
LABELING; LabelingSUPPL8AP2008-06-03
LABELING; LabelingSUPPL9AP2009-08-21
LABELING; LabelingSUPPL11AP2010-05-06
LABELING; LabelingSUPPL12AP2014-12-23STANDARD
LABELING; LabelingSUPPL13AP2016-12-27STANDARD
LABELING; LabelingSUPPL14AP2017-01-04STANDARD
LABELING; LabelingSUPPL15AP2021-08-30STANDARD
LABELING; LabelingSUPPL16AP2021-09-21STANDARD

Submissions Property Types

SUPPL9Null7
SUPPL12Null7
SUPPL13Null15
SUPPL14Null15
SUPPL15Null7
SUPPL16Null7

TE Codes

001PrescriptionAA

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 75514
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.